(Total Views: 155)
Posted On: 04/14/2023 12:25:45 PM
Post# of 126848

$HGEN News Article - Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia https://marketwirenews.com/news-releases/huma...84301.html


My Twitter: WhyteStocks